-
Mesoblast Achieves Target of 300 Treated Patients in Pivotal Phase 3 Trial for Chronic Low Back Pain
July 13, 2026 20:35 ET | Source: Mesoblast Limited NEW YORK, July 13, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has achieved its target of at least 300 patients treated in the MSB-DR004 pivotal Phase 3 randomized controlled trial of rexlemestrocel-L…
-
Forging India's Defence Future: Advancing Artillery Shell Manufacturing for Strategic Self-Reliance
India’s defence manufacturing sector is undergoing a pivotal transformation, and at the heart of this shift lies a capability that often goes unnoticed but is mission-critical – artillery shell manufacturing. These components, though rarely in the spotlight, form the very foundation of India’s ammunition strength. Their production is a matter of national security, industrial progress,…
-
India's Rise as a Strategic Capital Destination Gains Momentum: Baker Tilly ASA India Launches 'Doing Business in India'
New Delhi, Delhi, India Baker Tilly ASA India today marked 35 years of operations in India with the launch of its flagship publication, Doing Business in India – A Comprehensive Guide for Foreign Investors 2026. The 2026 edition comes at a pivotal moment as India consolidates its position as one of the world’s most dynamic…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.
